Conkwest Appoints Robert Rosen And Henry Ji To Its Board Of Directors

Conkwest, Inc. (the Natural Killer Cell Company of the West), an immuno-oncology company developing Neukoplast™ (NK-92™), a proprietary Natural Killer (NK) cell-line based therapy, announces the appointments of Robert Rosen and Henry Ji, Ph.D. to the Company’s Board of Directors. Mr. Rosen is President of Heron Therapeutics (NASDAQ:HRTX) and Dr. Ji is co-founder, President and CEO of Sorrento Therapeutics, Inc. (NASDAQ:SRNE).

Help employers find you! Check out all the jobs and post your resume.